• Simplify 340B with Dashboard Analytics

    Our powerful analytics platform provides users with robust and insightful visibility into their 340B program. With an intuitive, cloud-based platform, an advanced reporting machine, and reliable analytics, RxStrategies’ Dashboard Analytics solution simplifies your entire 340B program. Real-time accumulator views, WAC-spend analyses, robust drill-down capabilities, and custom report creations provide our users access to the exact… Read more »

  • 340B Program Compliance. Achieve More With Intuitive Solutions.

    It was great to connect with industry leaders during the 15th Annual 340B Coalition Winter Conference! As a pharmacist, clinic director, or C-suite executive, one of your top priorities is to provide safe and cost-effective care and ensure regulatory compliance.   RxStrategies understands the complexities of the 340B program and recognizes the importance of open communication… Read more »

  • Stay on Top of 340B this Summer

    We are proud to be a Pinnacle Leader Sponsor once again for the 2018 340B Coalition Summer Conference July 9-11 in Washington, D.C. The RxStrategies team is ready to connect with industry leaders at the conference while gaining insight and discussing the latest 340B trends and developments to stay on top of the 340B Program.… Read more »

  • Discover Program Compliance with RxStrategies

    At RxStrategies, we work with Covered Entities (CE) to create customized 340B solutions that proactively position CEs to maintain compliance implementing internal processes, controls and protocols for internal audits and review purposes. Our 340B CompliancePlus solution also promotes the benefits of engaging broad-based CE teams in program compliance and support and provides them with tools to… Read more »

  • Clinical Insights: July 14, 2017

    Welcome to the weekly edition of RxStrategies Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place.   New Drug Approval No new updates.   New Indication Approval Blincyto® (blinatumomab) – New Expanded Indication Approval – July 11, 2017 – Amgen announced that the U.S. Food and Drug… Read more »

  • Is Your 340B Program Audit Ready?

    340B Drug Pricing Program Covered Entities (CEs) must ensure program integrity and maintain accurate records documenting compliance with all 340B Program requirements, as follows: 340B Database information must remain accurate and up to date. New outpatient facilities and contract pharmacies must be registered as they are added. Recertify eligibility is necessary annually. Prevent diversion to… Read more »

  • Let’s Connect at HCP 2017 Spring Hospital Pharmacy Conference!

      Rhodie Smith and John Braff will be representing RxStrategies at the HCP 2017 Spring Hospital Pharmacy Conference, May 1 – 3 in Los Angeles.   We are looking forward to connecting with Hospital Pharmacy Directors from America’s most prestigious hospitals and health systems during the Reverse Expo sessions. Stop by the Supplier Showcase Booth #1104 to… Read more »

  • The Right Solution for 340B Program Compliance

    RxStrategies works with Covered Entities to provide an integrated approach to streamline the delivery of quality care, while maximizing savings and meeting the regulatory challenges associated with 340B program management. RxStrategies’ 340B solutions are key to a comprehensive and compliant 340B program. RxStrategies’ 340B CompliancePlus Audit Solution (Self-Audit Portal) Implement internal processes, controls and protocols… Read more »

  • RxStrategies’ Integrated 340B Solutions

    At RxStrategies, we work to remove the challenges organizations face when implementing 340B Drug Pricing Programs and make application possible by providing accountability, transparency and value-based 340B solutions. Our three main solutions: 340BPlus Split Billing Our Split Billing solution provides end-to-end 340B program management with a focus on program compliance. Manage, track, review and report… Read more »